Log in
RegisterRSABE - ANVISA [Regulatives / Guidelines]
Dear Maitri,
» Can any one comment on acceptability of Reference Scale Bioequivalence Approach for ANVISA ( Regulatory agency of Brazil) for highly variable drugs? Do they accept RSABE study design for Highly variable drug compunds?
Have you ever discovered the search field in the upper right corner of the forum?
Use it and you will find some threads dealing with the ANVISA specifications for scaled ABE. E.g. this one.
What do you think: If they have specifications for scaled ABE, do they accept studies using that approach?
» Can any one comment on acceptability of Reference Scale Bioequivalence Approach for ANVISA ( Regulatory agency of Brazil) for highly variable drugs? Do they accept RSABE study design for Highly variable drug compunds?
Have you ever discovered the search field in the upper right corner of the forum?
Use it and you will find some threads dealing with the ANVISA specifications for scaled ABE. E.g. this one.
What do you think: If they have specifications for scaled ABE, do they accept studies using that approach?
—
Regards,
Detlew
Regards,
Detlew
Complete thread:
- Reference Scale Average Bioequivalence Approach: ANVISA, Brazil Maitri 2018-09-21 19:49 [Regulatives / Guidelines]
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- RSABE - ANVISAd_labes 2018-09-22 14:11
Ing. Helmut Schütz